The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Extracellular matrix (ECM) stiffness and degradation as cancer drivers
Abstract
Alteration in the density and composition of extracellular matrix (ECM) occurs in tumors. The alterations toward both stiffness and degradation are contributed to tumor growth and progression. Cancer‐associated fibroblasts (CAFs) are the main contributors to ECM stiffness and degradation. The cells interact with almost all cells within the tumor microenvironment (TME) that could enable them to modulate ECM components for tumorigenic purposes. Cross‐talks between CAFs with cancer cells and macrophage type 2 (M2) cells are pivotal for ECM stiffness and degradation. CAFs induce hypoxia within the TME, which is one of the key inducers of both stiffness and degradation. Cancer cell modulatory roles in integrin receptors are key for adjusting ECM constituents to either fates. Cancer cell proliferation, migration, and invasion as well as angiogenesis are consequences of ECM stiffness and degradation. ECM stiffness in a transforming growth factor‐β (TGF‐β) related pathway could make a bridge in the basement membrane, and ECM degradation in a matrix metalloproteinase (MMP)‐related pathway could make a path in the TME, both of which contribute to cancer cell invasion. ECM stiffness is also obstructive for drug penetration to the tumor site. Therefore, it would be a promising strategy to make a homeostasis in ECM for easy penetration of chemotherapeutic drugs and increasing the efficacy of antitumor approaches. MMP and TGF‐β inhibitors, CAF and M2 reprogramming toward their normal counterparts, reduction of TME hypoxia and hampering integrin signaling are among the promising approaches for the modulation of ECM in favor of tumor regression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3726 · Cited by 1,520
Oxidative stress and cancer: An overview
Sosa, V., Moliné, T., Somoza, R., Paciucci, R., Kondoh, H., & LLeonart, M. E. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.10.004 · Cited by 1,439
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Chaudhuri, O., Koshy, S. T., Branco da Cunha, C., Shin, J.-W., Verbeke, C. S., Allison, K. H., & Mooney, D. J. (2014) · Nature Materials · doi:10.1038/nmat4009 · Cited by 820
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3841 · Cited by 767
Bourboulia, D., & Stetler-Stevenson, W. G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.002 · Cited by 710
A peek into cancer-associated fibroblasts: origins, functions and translational impact
LeBleu, V. S., & Kalluri, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.029447 · Cited by 537
Chen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
Gkretsi, V., & Stylianopoulos, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00145 · Cited by 390
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332
Wang, C., Tong, X., & Yang, F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5000828 · Cited by 261
Rahbari, N. N., Kedrin, D., Incio, J., Liu, H., Ho, W. W., Nia, H. T., Edrich, C. M., Jung, K., Daubriac, J., Chen, I., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5219 · Cited by 258
Zhao, P., Wang, Y., Kang, X., Wu, A., Yin, W., Tang, Y., Wang, J., Zhang, M., Duan, Y., & Huang, Y. (2018) · Chemical Science · doi:10.1039/c7sc04853j · Cited by 248
In vitro cancer cell–ECM interactions inform in vivo cancer treatment
Holle, A. W., Young, J. L., & Spatz, J. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.007 · Cited by 213
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
Purcell, J. W., Tanlimco, S. G., Hickson, J., Fox, M., Sho, M., Durkin, L., Uziel, T., Powers, R., Foster, K., McGonigal, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0327 · Cited by 205
Knudson, K. M., Hicks, K. C., Luo, X., Chen, J.-Q., Schlom, J., & Gameiro, S. R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1426519 · Cited by 195
McKenzie, A. J., Hicks, S. R., Svec, K. V., Naughton, H., Edmunds, Z. L., & Howe, A. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25589-0 · Cited by 192
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
Shibata, M., Ham, K., & Hoque, M. O. (2018) · International Journal of Cancer · doi:10.1002/ijc.31561 · Cited by 187
Paauwe, M., Schoonderwoerd, M. J. A., Helderman, R. F. C. P., Harryvan, T. J., Groenewoud, A., van Pelt, G. W., Bor, R., Hemmer, D. M., Versteeg, H. H., Snaar-Jagalska, B. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0329 · Cited by 167
Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
Tan, B., Shi, X., Zhang, J., Qin, J., Zhang, N., Ren, H., Qian, M., Siwko, S., Carmon, K., Liu, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0152 · Cited by 165
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation
Ahirwar, D. K., Nasser, M. W., Ouseph, M. M., Elbaz, M., Cuitiño, M. C., Kladney, R. D., Varikuti, S., Kaul, K., Satoskar, A. R., Ramaswamy, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0263-7 · Cited by 162
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 153
Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
Gouirand, V., Guillaumond, F., & Vasseur, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00117 · Cited by 148
Esbona, K., Yi, Y., Saha, S., Yu, M., Doorn, R. R. V., Conklin, M. W., Graham, D., Wisinski, K. B., Ponik, S. M., Eliceiri, K. W., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.025 · Cited by 135
Alonso‐Nocelo, M., Raimondo, T. M., Vining, K. H., López‐López, R., de la Fuente, M., & Mooney, D. J. (2018) · Biofabrication · doi:10.1088/1758-5090/aaafbc · Cited by 124
Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
Lam, W., Cao, L.-Z., Umesh, V., Keung, A. J., Sen, S., & Kumar, S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-35 · Cited by 123
Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells
Grasset, E. M., Bertero, T., Bozec, A., Friard, J., Bourget, I., Pisano, S., Lecacheur, M., Maiel, M., Bailleux, C., Emelyanov, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0601 · Cited by 122
Kesanakurti, D., Chetty, C., Dinh, D. H., Gujrati, M., & Rao, J. (2012) · Oncogene · doi:10.1038/onc.2012.52 · Cited by 119
Arandkar, S., Furth, N., Elisha, Y., Nataraj, N. B., van der Kuip, H., Yarden, Y., Aulitzky, W. E., Ulitsky, I., Geiger, B., & Oren, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719076115 · Cited by 116
Victor, B. C., Anbalagan, A., Mohamed, M. M., Sloane, B. F., & Cavallo‐Medved, D. (2011) · Breast Cancer Research · doi:10.1186/bcr3058 · Cited by 114
Stylianou, A., Gkretsi, V., & Stylianopoulos, T. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.02.009 · Cited by 110
The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
Alipoor, S. D., Mortaz, E., Varahram, M., Movassaghi, M., Kraneveld, A. D., Garssen, J., & Adcock, I. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00819 · Cited by 103
Quantifying solid stress and elastic energy from excised or in situ tumors
Nia, H. T., Datta, M., Seano, G., Huang, P., Munn, L. L., & Jain, R. K. (2018) · Nature Protocols · doi:10.1038/nprot.2018.020 · Cited by 97
Yue, X., Nguyen, T. D., Zellmer, V., Zhang, S., & Zorlutuna, P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.001 · Cited by 97
Li, A., Chen, P., Leng, Y., & Kang, J. (2018) · Oncogene · doi:10.1038/s41388-018-0379-9 · Cited by 91
Yu, Q., Xue, Y., Liu, J., Xi, Z., Li, Z., & Liu, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00130 · Cited by 89
Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation
Donnelly, S. K., Cabrera, R. M., Mao, S., Christin, J. R., Wu, B., Guo, W., Bravo‐Cordero, J. J., Condeelis, J. S., Segall, J. E., & Hodgson, L. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201704048 · Cited by 80
Proton irradiation orchestrates macrophage reprogramming through NFκB signaling
Genard, G., Wéra, A.-C., Huart, C., Calvé, B. L., Penninckx, S., Fattaccioli, A., Tabarrant, T., Demazy, C., Ninane, N., Heuskin, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0757-9 · Cited by 79
Martín-Villar, E., d’Água, B. B., Carrasco-Ramírez, P., Renart, J., Parsons, M., Quintanilla, M., & Jones, G. E. (2014) · Oncogene · doi:10.1038/onc.2014.388 · Cited by 78
ECM stiffness regulates glial migration in Drosophila and mammalian glioma models
Kim, S. N., Jeibmann, A., Halama, K., Witte, H. T., Wälte, M., Matzat, T., Schillers, H., Faber, C., Senner, V., Paulus, W., et al. (2014) · Development · doi:10.1242/dev.106039 · Cited by 74
Human hepatocellular carcinoma: Protection by melatonin
Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26586 · Cited by 72
Self-citationKrishnamachary, B., Stasinopoulos, I. A., Kakkad, S. M., Penet, M., Jacob, D., Wildes, F. B., Mironchik, Y., Pathak, A. P., Solaiyappan, M., & Bhujwalla, Z. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14912 · Cited by 70
Hammer, A. M., Sizemore, G. M., Shukla, V. C., Avendano, A., Sizemore, S. T., Chang, J. J., Kladney, R. D., Cuitiño, M. C., Thies, K., Verfurth, Q., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2017.04.004 · Cited by 64
Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours
Itoh, G., Chida, S., Yanagihara, K., Yashiro, M., Aiba, N., & Tanaka, M. (2017) · Oncogene · doi:10.1038/onc.2017.49 · Cited by 57
Fu, R., Zhang, Y., Li, H., Lv, W., Zhao, L., Guo, Q., Lu, T., Weiss, S. J., Li, Z., & Wu, Z. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14351 · Cited by 52
Donzelli, S., Milano, E., Pruszko, M., Sacconi, A., Masciarelli, S., Iosue, I., Melucci, E., Gallo, E., Terrenato, I., Mottolese, M., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0990-2 · Cited by 52
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
Lagares‐Tena, L., García-Monclús, S., López‐Alemany, R., Almacellas‐Rabaiget, O., Huertas-Martínez, J., Sáinz‐Jaspeado, M., Mateo‐Lozano, S., Galindo, C. R., Rello‐Varona, S., Herrero‐Martín, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10872 · Cited by 50
Katara, G. K., Kulshrestha, A., Mao, L., Wang, X., Sahoo, M., Ibrahim, S. A.-S., Pamarthy, S., Suzue, K., Shekhawat, G. S., Gilman‐Sachs, A., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12159 · Cited by 46
Cao, H., Eppinga, R., Razidlo, G. L., Krueger, E. W., Chen, J., Qiang, L., & McNiven, M. A. (2015) · Oncogene · doi:10.1038/onc.2015.163 · Cited by 44
Intravital microscopy in the study of the tumor microenvironment: from bench to human application
Gabriel, E. M., Fisher, D. T., Evans, S. S., Takabe, K., & Skitzki, J. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24957 · Cited by 43
Actopaxin (α-Parvin) Phosphorylation Is Required for Matrix Degradation and Cancer Cell Invasion
Pignatelli, J., LaLonde, S. E., LaLonde, D. P., Clarke, D. M., & Turner, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385229 · Cited by 41
Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration
Yamaguchi, R., & Perkins, G. A. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1470722 · Cited by 40
P300, A New Player in Mechanosensitivity and Activation of Cancer-Associated Fibroblasts
Torok, N. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.002 · Cited by 11
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Fu, T., Dai, L.-J., Wu, S.-Y., Xiao, Y., Ma, D., Jiang, Y.-Z., & Shao, Z.-M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01103-4 · Cited by 480
Metadata
- Authors
- Najafi, M., Farhood, B., & Mortezaee, K.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2018-10-15
- Volume
- 120
- Issue
- 3
- Pages
- 2782-2790
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2896737957
- Cited by
- 715
- References
- 59
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.